RNAi as a new therapeutic strategy against HCV.

MLA

Khaliq, Saba, et al. “RNAi as a New Therapeutic Strategy against HCV.” Biotechnology Advances, vol. 28, no. 1, Jan. 2010, pp. 27–34. EBSCOhost, https://doi.org/10.1016/j.biotechadv.2009.08.004.

APA

Khaliq, S., Khaliq, S. A., Zahur, M., Ijaz, B., Jahan, S., Ansar, M., Riazuddin, S., & Hassan, S. (2010). RNAi as a new therapeutic strategy against HCV. Biotechnology Advances, 28(1), 27–34. https://doi.org/10.1016/j.biotechadv.2009.08.004

Chicago

Khaliq, Saba, Sadaf A Khaliq, Muzna Zahur, Bushra Ijaz, Shah Jahan, Muhammad Ansar, Sheikh Riazuddin, and Sajida Hassan. 2010. “RNAi as a New Therapeutic Strategy against HCV.” Biotechnology Advances 28 (1): 27–34. doi:10.1016/j.biotechadv.2009.08.004.